It is well known that cancer cells are generated daily within the human body and are subsequently eliminated by the body's own immune system. Natural Killer (NK) cells are recognized as vital immune cells that play a crucial role in preventing the onset of cancer. The cytotoxic activity of these NK cells against cancer cells typically peaks around the age of 20 and declines due to aging and stress.

At our clinic, we expand and activate your own NK cells—which destroy cancer cells and virus-infected cells—and reinfuse them into your body via intravenous (IV) drip. Furthermore, we offer early cancer detection tests and immunological assessments to evaluate the presence of cancer and your overall immune function. This treatment is expected to reduce the risk of cancer development.

In cancer treatment, once the cancer has been reduced to a size undetectable by diagnostic imaging through therapies such as surgery, radiation, and chemotherapy, the patient enters a follow-up phase. This involves regular examinations to monitor for the emergence of any latent cancer cells. We recommend immune cell therapy during this 'invisible' stage as a proactive measure to prevent cancer recurrence.

The specific immune cell therapy we recommend depends on various factors, including the type of cancer, previous treatments, and whether your own cancer tissue has been cryopreserved. Additionally, high-sensitivity cancer detection tests and immunological assessments can be conducted to evaluate immune function and enable early detection of recurrence.

We believe that undergoing immune cell therapy at this particular timing offers the highest cost-effectiveness. We highly recommend this approach; please feel free to consult with us.

At our clinic, we strive to provide the most suitable cancer treatment for each individual patient. Our core approach is low-side-effect cancer therapy, supported by our unique culture technologies for NK cells and other lymphocytes, as well as dendritic cells. We achieve this by combining various methods and collaborating with other medical institutions.Activated Lymphocyte Therapy is a treatment that involves expanding and activating the patient's own immune cells—such as NK cells, γδT cells, αβT cells, and NKT cells—before administering them via intravenous infusion. Metaphorically speaking, these lymphocytes can be described as 'patrol officers' who can crack down on criminals even without a 'wanted poster' (pre-existing antigen information).

Dendritic Cell (DC) Therapy involves 'educating' T-lymphocytes about specific cancer antigens present in the patient's cancer cells. This process induces antigen-specific Cytotoxic T-Lymphocytes (CTLs) that can attack cancer more powerfully. To use an analogy, the dendritic cell acts as a 'Chief of Police' at the investigation headquarters, briefing investigators with 'wanted posters.

'Tumor-Infiltrating Lymphocyte (TIL) Therapy involves collecting CTLs that have entered ascites or pleural effusion in pursuit of cancer cells, reactivating them, and reinfusing them into the body. This can be likened to the 'reactivation of elite investigators' who have already been briefed with the 'wanted posters.'

Depending on the patient's condition, we propose the most effective plan by combining these various therapies.

Extensive research has been conducted globally regarding immunosenescence, ranging from lifestyle improvements—such as aerobic exercise and diets rich in nutrients like Vitamin C and D—to the development of pharmaceuticals aimed at mitigating aging itself. Despite these efforts, a definitive and effective treatment protocol has yet to be fully established.

The immune cell therapy provided at our clinic aims to prevent and improve immunosenescence by bolstering the body's innate natural defense mechanisms.

NK cell therapy is a well-documented treatment with numerous clinical cases reported both domestically and internationally.